Pittsburgh, PA, United States of America

George Michalopoulos

This inventor holds 22 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Cancer Treatment Methods. Top assignees: University of Pittsburgh, Other. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Michalopoulos. Retrieved from https://idiyas.com/inventor/george-michalopoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 77.3


 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Bethel, PA (US) (2004)
  • Decherd, TN (US) (2019 - 2020)
  • Joplin, MO (US) (2021)
  • Pittsburgh, PA (US) (2014 - 2022)
  • Los Angeles, CA (US) (2022)
  • Bay Harbor Islands, FL (US) (2024)

Company Filing History:

goldMedal15 out of 1,977 
 
University of Pittsburgh
 patents
silverMedal6 out of 834,771 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fusion Genes
Cancer Treatment
Inhalation Delivery
Prostate Cancer
Genomic Targeting
Protein Polymerization
Tissue Culture
Portable Lifting Device
Sanitary Wipes
Vitamin B12 Delivery
Pet Training Pad
Predicting Cancer Relapse
22 patents (USPTO):Explore Patents

Title: Innovations by George Michalopoulos: Pioneering Patents in Healthcare

Introduction

George Michalopoulos, based in Pittsburgh, PA, has made significant contributions to the fields of medicine and biotechnology, holding a remarkable total of 21 patents. His work primarily focuses on innovative delivery methods and genomic techniques for treating various medical conditions, particularly in the area of vitamin B12 supplementation and cancer treatment.

Latest Patents

Among his latest inventions is a patent for inhalation delivery methods and compositions for vitamin B12. This method effectively targets the delivery of vitamin B12 to individuals by positioning a delivery device that contains a mixture of the vitamin and water. The device, when activated, allows the user to inhale the mixture, which may include different forms of vitamin B12 such as cyanocobalamin and methylcobalamin. Notably, this mixture may also incorporate flavorings to enhance user experience, while explicitly avoiding certain additives like nicotine.

Additionally, Michalopoulos has developed methods for treating cells containing fusion genes through genomic targeting. This patented process offers new avenues for treating patients diagnosed with cancer or pre-malignant conditions by utilizing genome editing techniques aimed at inducing targeted cell death in cancer cells, thus providing an anti-cancer effect.

Career Highlights

Throughout his career, George Michalopoulos has been associated with prestigious institutions, including the University of Pittsburgh, where he has conducted pivotal research influencing his patent developments. His expertise in molecular medicine and biotechnology has positioned him as a leading innovator in these fields.

Collaborations

In his research endeavors, Michalopoulos has collaborated with several noteworthy professionals, including Jianhua Luo and Joel Byron Nelson. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking research and the successful implementation of his patented technologies.

Conclusion

George Michalopoulos exemplifies the spirit of innovation in the medical field with his extensive portfolio of patents that address critical health challenges. His contributions, particularly in the areas of vitamin B12 delivery and cancer treatment techniques, showcase the vital intersection of research and practical applications in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…